01 1Siegfried PharmaChemikalien Minden GmbH
01 1Oxymetazoline hydrochloride
01 1Switzerland
Registration Number : 220MF10107
Registrant's Address : Karlstrasse 15, 32423, Minden, Federal Republic of Germany
Initial Date of Registration : 2008-04-11
Latest Date of Registration : 2024-02-21
A Oxymetazoline Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxymetazoline Hydrochloride, including repackagers and relabelers. The FDA regulates Oxymetazoline Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxymetazoline Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Oxymetazoline Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Oxymetazoline Hydrochloride supplier is an individual or a company that provides Oxymetazoline Hydrochloride active pharmaceutical ingredient (API) or Oxymetazoline Hydrochloride finished formulations upon request. The Oxymetazoline Hydrochloride suppliers may include Oxymetazoline Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Oxymetazoline Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Oxymetazoline Hydrochloride Drug Master File in Japan (Oxymetazoline Hydrochloride JDMF) empowers Oxymetazoline Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Oxymetazoline Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Oxymetazoline Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Oxymetazoline Hydrochloride suppliers with JDMF on PharmaCompass.
We have 1 companies offering Oxymetazoline Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?